Skip to main content
VCbacked
Log inGet Started

Mable (Neurolytic Healthcare)

Oxford, United Kingdom

Genomics based individualized care for people with neurological conditions.

$3.2M raised
Jul 2022
Seed
Health CareMedicalNeuroscience

Top Investors

Y CombinatorCreative Destruction LabInitialized CapitalIlluminaArkitekt Ventures

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Mable (Neurolytic Healthcare)

How much funding has Mable (Neurolytic Healthcare) raised?
Mable (Neurolytic Healthcare) has raised $3.2M in total funding. The most recent round was Seed. The last funding was announced in July 2022.
Who are Mable (Neurolytic Healthcare)'s investors?
Mable (Neurolytic Healthcare)'s investors include Y Combinator, Creative Destruction Lab, Initialized Capital, Illumina, Arkitekt Ventures.
Where is Mable (Neurolytic Healthcare) headquartered?
Mable (Neurolytic Healthcare) is headquartered in Oxford, United Kingdom.
What does Mable (Neurolytic Healthcare) do?
Genomics based individualized care for people with neurological conditions.
What stage is Mable (Neurolytic Healthcare) at?
Mable (Neurolytic Healthcare) is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Mable (Neurolytic Healthcare) — Funding & Investors." VCBacked, July 27, 2022, https://www.vcbacked.co/company/mable-neurolytic-healthcare. Accessed July 1, 2026.
APA
VCBacked. (2022). Mable (Neurolytic Healthcare) — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/mable-neurolytic-healthcare
Wikipedia (cite web)
{{cite web |title=Mable (Neurolytic Healthcare) — Funding & Investors |url=https://www.vcbacked.co/company/mable-neurolytic-healthcare |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Oryl Photonics
Lausanne
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
OncoRevive
Brunswick$119K
Circl Brain Health Metrics
Victoria$354K
YLAH
Bern$589K